176 related articles for article (PubMed ID: 33222592)
1. Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status.
An J; Zhang Y; Muntner P; Moran AE; Hsu JW; Reynolds K
J Am Heart Assoc; 2020 Dec; 9(23):e017310. PubMed ID: 33222592
[TBL] [Abstract][Full Text] [Related]
2. Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
Muntner P; Orroth KK; Mues KE; Exter J; Shannon ED; Zaha R; Rosenson RS; Jackson EA
Cardiovasc Drugs Ther; 2022 Jun; 36(3):475-481. PubMed ID: 33661432
[TBL] [Abstract][Full Text] [Related]
3. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
4. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
Grandhi GR; Mszar R; Vahidy F; Valero-Elizondo J; Blankstein R; Blaha MJ; Virani SS; Andrieni JD; Omer SB; Nasir K
JAMA Cardiol; 2021 Jan; 6(1):87-91. PubMed ID: 32902562
[TBL] [Abstract][Full Text] [Related]
5. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
[TBL] [Abstract][Full Text] [Related]
6. Race/Ethnic and Sex Differences in the Association of Atherosclerotic Cardiovascular Disease Risk and Healthy Lifestyle Behaviors.
Morris AA; Ko YA; Hutcheson SH; Quyyumi A
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728015
[TBL] [Abstract][Full Text] [Related]
7. Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE Study.
d'Entremont MA; Ko D; Yan AT; Goodman SG; Ni J; Poirier P; Tardif JC; Grégoire JC; Couture ÉL; Nguyen M; Thanassoulis G; Sharma A; Huynh T
Can J Cardiol; 2023 Jul; 39(7):925-932. PubMed ID: 36914033
[TBL] [Abstract][Full Text] [Related]
8. Ischemic Event Rates in Very-High-Risk Adults.
Colantonio LD; Shannon ED; Orroth KK; Zaha R; Jackson EA; Rosenson RS; Exter J; Mues KE; Muntner P
J Am Coll Cardiol; 2019 Nov; 74(20):2496-2507. PubMed ID: 31727288
[TBL] [Abstract][Full Text] [Related]
9. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes.
Sinha A; Ning H; Cameron N; Bancks M; Carnethon MR; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
J Card Fail; 2023 Mar; 29(3):246-254. PubMed ID: 36343785
[TBL] [Abstract][Full Text] [Related]
12. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
Mahajan S; Grandhi GR; Valero-Elizondo J; Mszar R; Khera R; Acquah I; Yahya T; Virani SS; Blankstein R; Blaha MJ; Cainzos-Achirica M; Nasir K
J Am Heart Assoc; 2021 Aug; 10(16):e020028. PubMed ID: 34387089
[TBL] [Abstract][Full Text] [Related]
13. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
Wang AY; Wong MS; Humbyrd CJ
Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
[TBL] [Abstract][Full Text] [Related]
14. Trends in Lipid Screening Among Adults in an Integrated Health Care Delivery System, 2009-2015.
Grant DSL; Scott RD; Harrison TN; Cheetham TC; Chang SC; Hsu JY; Wei R; Boklage SH; Romo-LeTourneau V; Reynolds K
J Manag Care Spec Pharm; 2018 Nov; 24(11):1090-1101. PubMed ID: 30063170
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Poudel B; Rosenson RS; Bittner V; Gutiérrez OM; Anderson AH; Woodward M; Deo R; Carson AP; Mues KE; Dluzniewski PJ; Jaar BG; Lora CM; Taliercio J; Muntner P; Colantonio LD;
Kidney Med; 2021; 3(5):722-731.e1. PubMed ID: 34693254
[TBL] [Abstract][Full Text] [Related]
16. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
[TBL] [Abstract][Full Text] [Related]
17. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US.
Eberly LA; Yang L; Eneanya ND; Essien U; Julien H; Nathan AS; Khatana SAM; Dayoub EJ; Fanaroff AC; Giri J; Groeneveld PW; Adusumalli S
JAMA Netw Open; 2021 Apr; 4(4):e216139. PubMed ID: 33856475
[TBL] [Abstract][Full Text] [Related]
18. Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal.
Ngo-Metzger Q; Zuvekas S; Shafer P; Tracer H; Borsky AE; Bierman AS
J Am Board Fam Med; 2019; 32(6):807-817. PubMed ID: 31704749
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
